Literature DB >> 24749161

Reasons behind Greek problem drug users’ decisions to quit using drugs and engage in treatment of their own volition: sense of self and the Greek filotimo.

Maria Fotopoulou.   

Abstract

AIMS: The aim of this study was to explore Greek problem drug users’ perceptions of the reasons that led them to quit using drugs and engage in treatment of their own volition.
DESIGN: Qualitative semi-structured in-depth interviews.
SETTING: Two state drug agencies in Thessaloniki, Greece. PARTICIPANTS: A total of 40 adult problem drug-using men and women participated in the study. MEASUREMENTS: Participants were asked to reflect on their decisions to wean themselves from drugs and enter treatment. Findings Participants reported that their decisions centred on the re-conceptualization of the drug-using community and their membership in it, the desire to restore aspects of identities thatwere deemed to be spoiled, and finally memories of their drug-free selves. The importance of the distinctively Greek notion of filotimo in this discussion is highlighted.
CONCLUSIONS: Primarily in relation to filotimo (a concept that represents a complex array of virtues that regulates behaviour towards one’s family), the desire to restore one’s spoiled identity plays a pivotal role in Greek problem drug users’ decisions to cease drug use and engage in treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24749161     DOI: 10.1111/add.12459

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  2 in total

1.  Why Do Those With Long-Term Substance Use Disorders Stop Abusing Substances? A Qualitative Study.

Authors:  Henning Pettersen; Anne Landheim; Ivar Skeie; Stian Biong; Morten Brodahl; Victoria Benson; Larry Davidson
Journal:  Subst Abuse       Date:  2018-02-07

2.  HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates.

Authors:  Anastasios Fotiou; Eleftheria Kanavou; Argyro Antaraki; Clive Richardson; Manina Terzidou; Anna Kokkevi
Journal:  Hepatol Med Policy       Date:  2016-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.